NOUVELLE VÉSICULE À BASE DE MEMBRANE PLASMIQUE RECOMBINANTE POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

Tandem Co.; Ltd.

发明人:

申请号：

EP18862960.4

公开号：

EP3689337A1

申请日:

2018.09.28

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present invention relates to a recombinant plasma membrane-based vesicle, and more specifically to a recombinant plasma membrane-based vesicle comprising a VSV-G mutated protein in which histidine, the 162nd amino acid, has been substituted with arginine, and a pharmaceutical composition for treating cancer comprising the recombinant plasma membrane-based vesicle.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/